Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-05 Sale | 2024-07-08 5:59 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 1,337 | $2.5077 | $3,353 | 112,614 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:12 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 8,151 | $4.7888 | $39,034 | 78,951 (Direct) | View |
| 2024-01-03 Sale | 2024-01-08 06:03 am | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 2,413 | $3.1189 | $7,526 | 154,152 (Direct) | View |
| 2023-07-05 Sale | 2023-07-07 4:08 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 355 | $2.4537 | $871 | 55,945 (Direct) | View |
| 2023-01-04 Sale | 2023-01-05 8:25 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 820 | $5.5756 | $4,572 | 53,400 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 14,232 | $0 | 0 (Direct) | View |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 213,632 | $0 | 0 (Direct) | View |
| 2024-09-18 Option Award | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 16,100 | $0 | 0 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:34 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 35,000 | $0 | 113,951 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-08 06:03 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 100,620 | $0 | 154,152 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:19 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 35,000 | $0 | 56,300 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:25 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 48,200 | $0 | 53,400 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:25 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 32,500 | $0 | 32,520 (Direct) | View |
| 2021-08-16 Option Award | 2021-08-17 4:53 pm | N/A 2031-08-16 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 300,000 | $0 | 300,000 (Direct) | View |
Ownership | 2021-08-17 4:53 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 0 | $0 | 20 (Direct) | View |